Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1986 1
1987 1
1989 5
1990 1
1991 2
1992 3
1993 3
1994 1
1995 1
1996 4
1998 2
1999 3
2000 1
2001 1
2002 1
2004 1
2006 1
2007 1
2008 1
2009 4
2010 1
2011 1
2012 1
2014 2
2015 3
2016 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Review: implants.
Ashton P, Blandford DL, Pearson PA, Jaffe GJ, Martin DF, Nussenblatt RB. Ashton P, et al. Among authors: pearson pa. J Ocul Pharmacol. 1994 Winter;10(4):691-701. doi: 10.1089/jop.1994.10.691. J Ocul Pharmacol. 1994. PMID: 7714413 Review.
Triamcinolone crystal size.
Kleinman ME, Westhouse SJ, Ambati J, Pearson PA, Halperin LS. Kleinman ME, et al. Among authors: pearson pa. Ophthalmology. 2010 Aug;117(8):1654, 1654.e1-4. doi: 10.1016/j.ophtha.2010.01.052. Ophthalmology. 2010. PMID: 20682380 Free PMC article. No abstract available.
Ophthalmoplegic migraine with unusual features.
O'Halloran HS, Lee WB, Baker RS, Pearson PA. O'Halloran HS, et al. Among authors: pearson pa. Headache. 1999 Oct;39(9):670-3. doi: 10.1046/j.1526-4610.1999.3909670.x. Headache. 1999. PMID: 11279964 Review.
Intravitreal sustained-release ganciclovir.
Smith TJ, Pearson PA, Blandford DL, Brown JD, Goins KA, Hollins JL, Schmeisser ET, Glavinos P, Baldwin LB, Ashton P. Smith TJ, et al. Among authors: pearson pa. Arch Ophthalmol. 1992 Feb;110(2):255-8. doi: 10.1001/archopht.1992.01080140111037. Arch Ophthalmol. 1992. PMID: 1310588
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group. Scott IU, et al. JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352. JAMA Ophthalmol. 2022. PMID: 35323843 Free PMC article. Clinical Trial.
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.
Sustained release intravitreal dexamethasone.
Hainsworth DP, Pearson PA, Conklin JD, Ashton P. Hainsworth DP, et al. Among authors: pearson pa. J Ocul Pharmacol Ther. 1996 Spring;12(1):57-63. doi: 10.1089/jop.1996.12.57. J Ocul Pharmacol Ther. 1996. PMID: 8925398
49 results